← back to search

Ying Zhang

Guangzhou University of Chinese Medicine · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Hepatocellular carcinoma and Cancer research, with related work in Microvesicles, Downregulation and upregulation, Gene knockdown. Notable publications include 'Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma', 'Effects of dialysis modality choice on the survival of end-stage renal disease patients in southern China: a retrospective cohort study', and 'Jianpi Huayu decoction inhibits the epithelial–mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling'.
h-index
citations
125
works
8
NIH funding
primary concept
email

Recent publications

Jianpi Huayu decoction enhances the antitumor effect of doxorubicin via piezo1-mediated autophagy in hepatocellular carcinoma
Phytomedicine 2025cited by 5position: middledoi
Hepatectomy versus transcatheter arterial chemoembolization for resectable BCLC stage A/B hepatocellular carcinoma beyond Milan criteria: A randomized clinical trial
Frontiers in Oncology 2023cited by 9position: middledoi
Adjuvant therapy with Jianpi Huayu decoction improves overall and recurrence-free survival after hepatectomy for hepatocellular carcinoma: a retrospective propensity score-matching study
Frontiers in Pharmacology 2023cited by 7position: middledoi
Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
Scientific Reports 2022cited by 49position: middledoi
Jianpi Huayu decoction inhibits the epithelial–mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling
Journal of Ethnopharmacology 2022cited by 13position: middledoi
JPHYD Inhibits miR-21-5p/Smad7-Mediated Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells
Journal of Oncology 2022cited by 11position: middledoi
CircFGGY Inhibits Cell Growth, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma via Regulating the miR-545-3p/Smad7 Axis
Frontiers in Cell and Developmental Biology 2022cited by 7position: middledoi
Effects of dialysis modality choice on the survival of end-stage renal disease patients in southern China: a retrospective cohort study
BMC Nephrology 2020cited by 24position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chong Zhong · Guangzhou University of Chinese Medicine7 papers (2022–2025)Chongkai Fang · Guangzhou University of Chinese Medicine7 papers (2022–2025)Kun-Liang Feng · Guangzhou University of Chinese Medicine6 papers (2022–2023)Rui Luo · Guangzhou University of Chinese Medicine6 papers (2022–2025)Ji-Nan Wang · Guangzhou University of Chinese Medicine3 papers (2022–2022)Jinan Wang · Guangzhou University of Chinese Medicine3 papers (2022–2023)Ruiwei Yao · Guangzhou University of Chinese Medicine3 papers (2023–2025)Silin Liu · Guangzhou University of Chinese Medicine2 papers (2022–2023)Hanqian Shi · Guangzhou University of Chinese Medicine2 papers (2023–2023)Chuyao Chen · Guangzhou University of Chinese Medicine2 papers (2023–2025)Jing Li · Guangzhou University of Chinese Medicine1 papers (2025–2025)Xusheng Liu · Guangzhou University of Chinese Medicine1 papers (2020–2020)Junyan Wang · Guangzhou University of Chinese Medicine1 papers (2022–2022)Chaoyuan Huang · Guangzhou University of Chinese Medicine1 papers (2022–2022)Peng Yu · Guangzhou University of Chinese Medicine1 papers (2020–2020)Haijing Hou · Guangzhou University of Chinese Medicine1 papers (2020–2020)Mingli Hu · Guizhou University1 papers (2023–2023)Chunfeng Xie · Guangzhou University of Chinese Medicine1 papers (2022–2022)Daixin Zhao · Guangzhou University of Chinese Medicine1 papers (2020–2020)Jingyao Huang · Guangzhou University of Chinese Medicine1 papers (2020–2020)